论文部分内容阅读
为探讨DNA倍数、激素受体、脉管受侵(VSI)、血管周围淋巴细胞(PVL)和癌基因HFR-2/neu、p 53及bcl-2作为临床Ⅰ期宫内膜癌淋巴结转移和复发的预后判断指标进行下述研究。 1984～1992年手术治疗临床Ⅰ期宫内膜癌349例,除外病变超出子宫体(附件、腹水细胞阳性、宫颈),侵犯浆膜、病理为乳头状浆液性及透明细胞癌的患者。分期手术时有淋巴结转移或癌复发者31例,包括淋巴结转移但无复发7例,淋巴结转移并复
To investigate the relationship between DNA multiple, hormone receptor, vascular invasion (VSI), perivascular lymphocytes (PVL) and oncogenes HFR-2 / neu, p 53 and bcl-2 as clinical stage Ⅰ endometrial cancer lymph node metastasis and Recurrence of prognostic indicators for the following study. Surgical treatment of clinical stage Ⅰ endometrial cancer from 1984 to 1992, 349 cases, except lesions beyond the uterus (annex, ascites cells positive, cervical), serosal invasion, pathological papillary serous and clear cell carcinoma patients. There were 31 cases of lymph node metastasis or cancer recurrence in staging operation, including 7 cases of lymph node metastasis but no recurrence, lymph node metastasis and complex